Campaign

Company Summary :

AuriGen Medical is transforming stroke prevention with its Zenith device, designed to address key unmet market needs.

Key highlights:

• Promising Clinical Results: Initial First-in-Human trials  show complication-free outcomes, and strong feedback from experienced LAAO users emphasizes Zenith’s competitive advantages..
• Growing Market Potential: LAAO market projected to expand from $2B in 2023 to $10B by 2032
• Competitive Advantage: Zenith tackles thrombus and leaks with real-time detection, repositioning, and a self-closing membrane for easier implantation.
• Market Opportunity: Positioned to address unmet needs, competing with leaders in the growing LAAO market, with plans for rapid entry and global expansion backed by strong data.